Arbutus Biopharma (ABUS) received a Notice of Allowance for its US patent application 16/312,162 titled "COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA" - Patent Grants

July 30, 2021 2:01 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Arbutus Biopharma (NASDAQ: ABUS) received a Notice of Allowance for its US patent application 16/312,162 titled "COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA" - Patent Grants



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News